Cancer research

In 1956, SRI began a still-continuing series of research projects in synthesis of possible anticancer agents for the National Institutes of Health (NIH).

The first of many NIH contracts lasted for 25 years, and SRI published more than 100 articles in the field of cancer chemotherapy in refereed journals. These papers, plus innumerable presentations at symposia, put SRI on the map in the field of cancer research.

In 2011, the National Cancer Institute awarded SRI two five-year contracts to examine the safety and efficacy of several potential treatments for cancer and other diseases of critical importance to the nation’s health.